Form of Delivery — Nanoaerosol
Researchers from Siberian RAS, Novosibirsk Research Institute of Tuberculosis and drug manufacturers offer new drugs for treatment with tuberculosis. The specific of the drug lies in its method of shipment to the focus of infection. The drug will be available not be in the form of tablets or injections, but as an inhaled nanoaerosol.
Researchers of the new drug consider this innovative form of drug delivery will help control the dose, excluding the overdose, will help reduce the incidence of side effects and increase the effectiveness of the drugs.
Researchers from Novosibirsk have been long involved in development of inhalation forms of nanoaerosols and calculation of their therapeutic dose. They performed tests on over 40 pharmaceutical substances. They selected six substances to continue the work. In near future Novosibirsk Research Institute of Tuberculosis will start preclinical trials, and then clinical trials of new pharmaceutical forms.